Chronic lymphocytic leukaemia: A model for investigating potential new targets for the therapy of indolent lymphomas

Federico Caligaris-Cappio, Alessandro Cignetti, Luisa Granziero, Paolo Ghia

Research output: Contribution to journalArticle

Abstract

We address two key issues whose investigation may help to define new prognostic parameters and new potential targets for therapeutic intervention. First, which are the conceptual implications of the cellular origin of indolent lymphomas? Second, how may deciphering the biology of chronic lymphocytic leukaemia (CLL) lead to the development of new modalities of treatment? The latter issue is articulated in the following three key questions. (1) Which are the molecular pathways through which the microenvironment exerts its influence on the malignant clone? (2) What are the relationships between proliferation and defective apoptosis? (3)Is there any evidence of a role for antigenic stimulation?

Original languageEnglish
Pages (from-to)563-575
Number of pages13
JournalBest Practice and Research: Clinical Haematology
Volume15
Issue number3
DOIs
Publication statusPublished - 2002

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Lymphoma
Clone Cells
Apoptosis
Therapeutics

Keywords

  • Apoptosis
  • B lymphocytes
  • Chronic lymphocytic leukaemia
  • Indolent lymphomas
  • Microenvironment

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chronic lymphocytic leukaemia : A model for investigating potential new targets for the therapy of indolent lymphomas. / Caligaris-Cappio, Federico; Cignetti, Alessandro; Granziero, Luisa; Ghia, Paolo.

In: Best Practice and Research: Clinical Haematology, Vol. 15, No. 3, 2002, p. 563-575.

Research output: Contribution to journalArticle

@article{b0503e18e9444655b5bea7714aab48e1,
title = "Chronic lymphocytic leukaemia: A model for investigating potential new targets for the therapy of indolent lymphomas",
abstract = "We address two key issues whose investigation may help to define new prognostic parameters and new potential targets for therapeutic intervention. First, which are the conceptual implications of the cellular origin of indolent lymphomas? Second, how may deciphering the biology of chronic lymphocytic leukaemia (CLL) lead to the development of new modalities of treatment? The latter issue is articulated in the following three key questions. (1) Which are the molecular pathways through which the microenvironment exerts its influence on the malignant clone? (2) What are the relationships between proliferation and defective apoptosis? (3)Is there any evidence of a role for antigenic stimulation?",
keywords = "Apoptosis, B lymphocytes, Chronic lymphocytic leukaemia, Indolent lymphomas, Microenvironment",
author = "Federico Caligaris-Cappio and Alessandro Cignetti and Luisa Granziero and Paolo Ghia",
year = "2002",
doi = "10.1053/beha.2002.0212",
language = "English",
volume = "15",
pages = "563--575",
journal = "Best Practice and Research in Clinical Haematology",
issn = "1521-6926",
publisher = "Bailliere Tindall Ltd",
number = "3",

}

TY - JOUR

T1 - Chronic lymphocytic leukaemia

T2 - A model for investigating potential new targets for the therapy of indolent lymphomas

AU - Caligaris-Cappio, Federico

AU - Cignetti, Alessandro

AU - Granziero, Luisa

AU - Ghia, Paolo

PY - 2002

Y1 - 2002

N2 - We address two key issues whose investigation may help to define new prognostic parameters and new potential targets for therapeutic intervention. First, which are the conceptual implications of the cellular origin of indolent lymphomas? Second, how may deciphering the biology of chronic lymphocytic leukaemia (CLL) lead to the development of new modalities of treatment? The latter issue is articulated in the following three key questions. (1) Which are the molecular pathways through which the microenvironment exerts its influence on the malignant clone? (2) What are the relationships between proliferation and defective apoptosis? (3)Is there any evidence of a role for antigenic stimulation?

AB - We address two key issues whose investigation may help to define new prognostic parameters and new potential targets for therapeutic intervention. First, which are the conceptual implications of the cellular origin of indolent lymphomas? Second, how may deciphering the biology of chronic lymphocytic leukaemia (CLL) lead to the development of new modalities of treatment? The latter issue is articulated in the following three key questions. (1) Which are the molecular pathways through which the microenvironment exerts its influence on the malignant clone? (2) What are the relationships between proliferation and defective apoptosis? (3)Is there any evidence of a role for antigenic stimulation?

KW - Apoptosis

KW - B lymphocytes

KW - Chronic lymphocytic leukaemia

KW - Indolent lymphomas

KW - Microenvironment

UR - http://www.scopus.com/inward/record.url?scp=0036455059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036455059&partnerID=8YFLogxK

U2 - 10.1053/beha.2002.0212

DO - 10.1053/beha.2002.0212

M3 - Article

C2 - 12468406

AN - SCOPUS:0036455059

VL - 15

SP - 563

EP - 575

JO - Best Practice and Research in Clinical Haematology

JF - Best Practice and Research in Clinical Haematology

SN - 1521-6926

IS - 3

ER -